Glucose-Sensitive Cftr Suppresses Glucagon Secretion by Potentiating K-Atp Channels in Pancreatic Islet Alpha Cells

Wen Qing Huang,Jing Hui Guo,Xiao Hu Zhang,Mei Kuen Yu,Yiu Wa Chung,Ye Chun Ruan,Hsiao Chang Chan
DOI: https://doi.org/10.1210/en.2017-00282
IF: 5.051
2017-01-01
Endocrinology
Abstract:The secretion of glucagon by islet alpha cells is normally suppressed by high blood glucose, but this suppressibility is impaired in patients with diabetes or cystic fibrosis (CF), a disease caused by mutations in the gene encoding CF transmembrane conductance regulator (CFTR), a cyclic adenosine monophosphate-activated Cl- channel. However, precisely how glucose regulates glucagon release remains controversial. Here we report that elevated glucagon secretion, together with increased glucose-induced membrane depolarization and Ca2+ response, is found in CFTR mutant (DF508) mice/islets compared with the wild-type. Overexpression of CFTR in AlphaTC1-9 cells results in membrane hyperpolarization and reduced glucagon release, which can be reversed by CFTR inhibition. CFTR is found to potentiate the adenosine triphosphate-sensitive K+ (K-ATP) channel because membrane depolarization and whole-cell currents sensitive to K-ATP blockers are significantly greater in wild-type/CFTR-overexpressed alpha cells compared with that in DF508/non-overexpressed cells. K-ATP knockdown also reverses the suppressive effect of CFTR overexpression on glucagon secretion. The results reveal that by potentiating K-ATP channels, CFTR acts as a glucose-sensing negative regulator of glucagon secretion in alpha cells, a defect of which may contribute to glucose intolerance in CF and other types of diabetes.
What problem does this paper attempt to address?